"In October 2014 the Company, which had previously owned 49% of MAvPby assumption of all of Implex’s responsibilities to the lenders, obtained the other 51% from Implex and, accordingly, is now the owner of 100% of the issued and outstanding stock of that compounding pharmacy. The Implex ownership interest in MAvP was transferred to the Company for no additional consideration as the Company previously reflected 100% of the purchase price through VIE consolidation. The Company now owns 100% of the assets and outstanding common stock of MAvP."